Teva, Novartis Settle Suit Over Generic Famvir
Teva Pharmaceuticals USA Inc. will make a one-time payment to Novartis and pay ongoing royalties on future U.S. sales of the generic in exchange for a release from liability, Teva said.
No other terms were released, and a representative for Novartis could not immediately be reached for comment Tuesday. Settlement documents have not been filed in the case, which is...
To view the full article, register now.